chr6-32581554-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002124.4(HLA-DRB1):c.652+3G>A variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00010 ( 0 hom., cov: 10)
Exomes 𝑓: 0.00049 ( 6 hom. )
Consequence
HLA-DRB1
NM_002124.4 splice_donor_region, intron
NM_002124.4 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.00001678
2
Clinical Significance
Conservation
PhyloP100: 0.828
Genes affected
HLA-DRB1 (HGNC:4948): (major histocompatibility complex, class II, DR beta 1) HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes the transmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and some alleles have increased frequencies associated with certain diseases or conditions. For example, DRB1*1302 has been related to acute and chronic hepatitis B virus persistence. There are multiple pseudogenes of this gene. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 6-32581554-C-T is Benign according to our data. Variant chr6-32581554-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2656459.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HLA-DRB1 | NM_002124.4 | c.652+3G>A | splice_donor_region_variant, intron_variant | ENST00000360004.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HLA-DRB1 | ENST00000360004.6 | c.652+3G>A | splice_donor_region_variant, intron_variant | NM_002124.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000103 AC: 8AN: 77540Hom.: 0 Cov.: 10
GnomAD3 genomes
AF:
AC:
8
AN:
77540
Hom.:
Cov.:
10
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00333 AC: 597AN: 179480Hom.: 5 AF XY: 0.00329 AC XY: 325AN XY: 98676
GnomAD3 exomes
AF:
AC:
597
AN:
179480
Hom.:
AF XY:
AC XY:
325
AN XY:
98676
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000491 AC: 492AN: 1001462Hom.: 6 Cov.: 17 AF XY: 0.000622 AC XY: 315AN XY: 506456
GnomAD4 exome
AF:
AC:
492
AN:
1001462
Hom.:
Cov.:
17
AF XY:
AC XY:
315
AN XY:
506456
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000103 AC: 8AN: 77616Hom.: 0 Cov.: 10 AF XY: 0.000188 AC XY: 7AN XY: 37288
GnomAD4 genome
AF:
AC:
8
AN:
77616
Hom.:
Cov.:
10
AF XY:
AC XY:
7
AN XY:
37288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | HLA-DRB1: BP4, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at